#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Gastric cancer+6

Not yet recruiting

InvestigationalNo placebo

Phase 2 Study of Lirafugratinib in Patients with Previously Treated Unresectable Advanced Solid Tumors with FGFR2 Fusion (Excluding Cholangiocarcinoma)

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years

Contact Research Centre

Gastric cancer

Not yet recruiting

InvestigationalNo placebo

Diagnostic Accuracy of [18F]FAPI-74 PET/CT for Detecting Metastasis and Assessing Treatment Response in Gastric Cancer Patients

InvestigationalNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:[Al[18F]F]Fapi-74

Contact Research Centre

Gastric cancer

Not yet recruiting

Registered drugNo placebo

68Ga-FAPI-46 PET-CT for Initial Staging of Gastric Cancer in Patients Eligible for Curative Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Gastric cancer+7

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:SGN-ALPV

Contact Research Centre

Gastric cancer

Not yet recruiting

Registered drug

Study on Preoperative Iron Infusion with Ferric Carboxymaltose for Patients with Stomach Cancer

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Gastric cancer+6

Not yet recruiting

InvestigationalNo placebo

Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Gastric cancer+2

Not yet recruiting

Registered drugNo placebo

Study of Disitamab Vedotin and Tucatinib for Patients with Advanced Breast Cancer or Gastric Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Disitamab Vedotin

Contact Research Centre

Gastric cancer+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of AZD0901 Compared to Standard Treatments for Adults with Advanced Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azd0901

Contact Research Centre

Gastric cancer+1

Not recruiting

Registered drug

Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Gastric cancer+6

Not recruiting

InvestigationalNo placebo

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cldn6 Car-T

Contact Research Centre

Gastric cancer+3

Not recruiting

Registered drug

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Gastric cancer

Not recruiting

Registered drugNo placebo

Study of FOLFIRI with Domvanalimab and Zimberelimab in patients with advanced gastric or gastro-esophageal junction cancer who progressed after chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.